Arvid. W. A. Kamps

Arvid. W. A. Kamps

Auto-generated profile, based on publicly available information

Arvid. W. A. Kamps

Department of Paediatrics Martini Hospital Groningen The Netherlands

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2001 in Thorax
Verified
Journal Article
Open access
PDF file
AKA W A Kamps
A W A Kamps
RRR J Roorda
R J Roorda
PBP L P Brand
P L P Brand
BACKGROUND A study was undertaken to investigate the compliance with and accuracy of peak flow diaries in childhood asthma. METHODS Forty asthmatic children (5–16 years) were asked to perform peak flow measurements twice daily for 4 weeks by means of an electronic peak flow meter and to record values in a written diary. Patients and parents were unaware that the device stored the peak flow values on a microchip. In random order, half of the patients were only told that the device allowed for more accurate assessment of peak flow while the other half were told that accurate recording of peak flow was important because the results would be used in guiding adjustments to treatment. Data in the written diary (reported data) were compared with those from the electronic diary (actual data). RESULTS In the entire study population the mean (SD) actual compliance (77.1 (20.5)%) was much lower than the mean reported compliance (95.7 (9.1)%) (95% CI for difference 12.7% to 24.4%) The percentage of correct peak flow entries decreased from 56% to <50% from the first to the last study week (p<0.04), mainly as a result of an increase in self-invented peak flow entries. Results were comparable for both groups. For incorrect peak flow entries the mean difference between written and electronically recorded entries ranged from –72 to 34 l/min per patient. CONCLUSIONS Peak flow diaries kept by asthmatic children are unreliable. Electronic peak flow meters should be used if peak flow monitoring is required in children with asthma.

1 November 2003 in Thorax
Verified
Journal Article
Open access
PDF file
AKA W A Kamps
A W A Kamps
PBP L P Brand
P L P Brand
JKJ L L Kimpen
J L L Kimpen
AMA R Maillé
A R Maillé
AGA W Overgoor-Van de Groes
A W Overgoor-Van de Groes
RRR J Roorda
R J Roorda
Background: Until now, care provided by asthma nurses has been additional to care provided by paediatricians. A study was undertaken to compare nurse led outpatient management of childhood asthma with follow up by a paediatrician. Methods: Seventy four children referred because of insufficient control of persistent asthma were randomly allocated to 1 year follow up by a paediatrician or asthma nurse. The main outcome measure was the percentage of symptom-free days. Additional outcome measures were airway hyperresponsiveness, lung function, daily dose of inhaled corticosteroids (ICS), number of exacerbations, number of additional visits to the general practitioner, absence from school, functional health status, and disease specific quality of life. Results: There were no significant differences at the end of the 1 year study period between the two treatment groups in percentage of symptom-free days (mean difference 2.5%; 95% CI −8.8 to 13.8), airway hyperresponsiveness (log10 PD20 0.06; −0.19 to 0.32), functional health status (10.1; −0.3 to 19.8), disease specific quality of life of patients (0.08; −0.9 to 0.7), and disease specific quality of life of caregivers (0.09; −0.2 to 0.3), nor in any other outcome parameters. Most outcome parameters improved considerably over the 1 year study period. These improvements were achieved although the daily dose of ICS was reduced by a mean of 26% compared with the dose received by children at referral. All parents were satisfied with the asthma care received. Conclusions: After initial assessment in a multidisciplinary clinic, childhood asthma can be successfully managed by an asthma nurse in close cooperation with a paediatrician. During close follow up by paediatrician or asthma nurse, asthma control improved despite a reduction in ICS dose.

1 February 2004 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
AKA.W.A. Kamps
A.W.A. Kamps
RRR.J. Roorda
R.J. Roorda
JKJ.L.L. Kimpen
J.L.L. Kimpen
AGA.W. Overgoor-Van de Groes
A.W. Overgoor-Van de Groes
LHL.C.J.A.M. van Helsdingen-Peek
L.C.J.A.M. van Helsdingen-Peek
PBP.L.P. Brand
P.L.P. Brand
The high burden of asthma on healthcare utilisation and costs warrants economic appraisal of management approaches. The authors previously demonstrated that the efficacy of nurse-led outpatient management of childhood asthma was comparable to management by a paediatrician and now report on the healthcare utilisation and costs of both management approaches.A total of 74 newly referred children with asthma were randomly assigned to a 1‐yr follow-up by paediatricians or asthma nurse. Healthcare utilisation was recorded and associated costs calculated for both management approaches.There were no significant differences in healthcare utilisation except for the total time spent on patient contact (136(n=14)versus187(n=41) min, for patients followed-up by paediatrician and an asthma nurse repectively). Costs within the healthcare sector were reduced by 7.2% in favour of nurse-led care. The reduction in costs was solely attributable to a 17.5% reduction in the costs of outpatient visits. Nurse-led care appeared to be cost-saving even if the duration of follow-up visits would be twice that of doctor's visits. Overall healthcare costs (within and outside the healthcare sector) were 4.1% lower for nurse-led outpatient management compared to traditional medical care.Nurse-led outpatient management of childhood asthma can be provided at a lower cost than medical care by paediatricians.

29 May 2014 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
AKArvid W.A. Kamps
Arvid W.A. Kamps
MMMarco Molenmaker
Marco Molenmaker
RKRamses Kemperman
Ramses Kemperman
BVBetty S. van der Veen
Betty S. van der Veen
GBGianni Bocca
Gianni Bocca
NVNic J.G.M. Veeger
Nic J.G.M. Veeger

11 December 2003 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
AKArvid W.A. Kamps
Arvid W.A. Kamps
PBPaul L.P. Brand
Paul L.P. Brand
RRRuurd Jan Roorda
Ruurd Jan Roorda

1 September 2015 in Respiratory Care
Verified
Journal Article
Open access
PDF file
TFTina E Faber
Tina E Faber
AKArvid Wa Kamps
Arvid Wa Kamps
MSMachtelt H Sjoerdsma
Machtelt H Sjoerdsma
SVStephanie Vermeulen
Stephanie Vermeulen
NVNic Jgm Veeger
Nic Jgm Veeger
LBLouis J Bont
Louis J Bont
BACKGROUND: Studies suggest an effect of nebulized hypertonic saline solution on air-flow limitation in subjects with respiratory syncytial virus (RSV) bronchiolitis, but results are based on subjective scores of clinical severity and are not clear. In this observational study, we used a noninvasive computerized tool to quantify wheezing before and after nebulization with hypertonic saline in children admitted for RSV infection. METHODS: Twenty-seven children (≤ 24 months old) admitted to the pediatric ward of the Medical Center Leeuwarden with polymerase chain reaction-confirmed RSV bronchiolitis were included. Subjects were simultaneously assessed both clinically and by computerized acoustic monitoring before and 15 min after treatment with nebulized hypertonic saline solution. RESULTS: Clinical assessment, defined by the Respiratory Distress Assessment Instrument score, did not change after nebulization ( n = 27, 5.0 vs 4.7, P = .17). Computerized acoustic monitoring showed no improvement in wheezing ( n = 27, 3.4% vs 2.0%, P = .05) or inspiration/expiration ratio (0.85 vs 0.85, P = .93) after nebulization. CONCLUSIONS: Hypertonic saline nebulization does not improve air flow, as assessed by both clinical and computerized acoustic scores, in children admitted for RSV.